User:Korbin H.J. West/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 18: Line 18:
The activation of NF- κB occurs in a few different pathways; however, the most prominent are the canonical and the non-canonical pathways. In the canonical pathway, NF- κB is normally in an inactive dimer form in the cytosol, bound to an inhibitor kappa-B protein (IκB). The binding of IκB interferes with nuclear localization signal of NF- κB, which as in case of the p50 homodimer is found *** just beyond the last ordered residues***. According to Muller et al., I-κB may inhibit DNA binding of NF-κB through a few different ways. I-κB is a large enough protein that is could interfere with NF-κB-DNA contact directly by inserting itself in the groove between the two. On the other hand, it could just interact with the N-terminal domain to change the angle needed for DNA binding.
The activation of NF- κB occurs in a few different pathways; however, the most prominent are the canonical and the non-canonical pathways. In the canonical pathway, NF- κB is normally in an inactive dimer form in the cytosol, bound to an inhibitor kappa-B protein (IκB). The binding of IκB interferes with nuclear localization signal of NF- κB, which as in case of the p50 homodimer is found *** just beyond the last ordered residues***. According to Muller et al., I-κB may inhibit DNA binding of NF-κB through a few different ways. I-κB is a large enough protein that is could interfere with NF-κB-DNA contact directly by inserting itself in the groove between the two. On the other hand, it could just interact with the N-terminal domain to change the angle needed for DNA binding.
-
Once a ligand binds to a cellular receptor, the signal is relayed through adaptors such as TRAFs to an IκB kinase (IKK) complex. The canonical IKK complex is built up by alpha and beta catalytic subunits and two regulatory scaffold NF-κB essential modulator (NEMO) proteins. This IKK complex is activated by clusters of adaptors, and upon activation it will phosphorylate the IκB. Once phosphorylated, IκB is subsequently ubiquitinated and degraded by the proteasome. With its inhibitor degraded, NF- κB’s nuclear localization signal is freed, allowing it to move to the nucleus and bind to κB sites of DNA to prompt transcription. These <scene name='71/714934/Real_dna_sites/1'>κB sites</scene> are usually 9-10 base pairs that follow the general form 5'-GGGRNWYYCC-3' (R: A or G; N: any nucleotide; W: A or T; Y: C or T)<ref>DOI 10.1038/sj.onc.1209954</ref>. In the scene, Gs are pink, As are blue, Ts are blue, and Cs are yellow, and we see that it follows the general form well.
+
Once a ligand binds to a cellular receptor, the signal is relayed through adaptors such as TRAFs to an IκB kinase (IKK) complex. The canonical IKK complex is built up by alpha and beta catalytic subunits and two regulatory scaffold NF-κB essential modulator (NEMO) proteins. This IKK complex is activated by clusters of adaptors, and upon activation it will phosphorylate the IκB. Once phosphorylated, IκB is subsequently ubiquitinated and degraded by the proteasome. With its inhibitor degraded, NF- κB’s nuclear localization signal is freed, allowing it to move to the nucleus and bind to κB sites of DNA to prompt transcription. These <scene name='71/714934/Real_dna_sites/1'>κB sites</scene> are usually 9-10 base pairs that follow the general form 5'-GGGRNWYYCC-3' (R: A or G; N: any nucleotide; W: A or T; Y: C or T)<ref>DOI 10.1038/sj.onc.1209954</ref>. In the scene, Gs are pink, As are blue, Ts are green, and Cs are yellow, and we see that it follows the general form well.
Alternatively, NF- κB can be activated through the non-canonical pathway, however it affects mainly p100/RelB complexes. The non-canonical pathway is initiated upon binding of very specific ligands (B-cell activating factor, CD40, etc.). This cellular signal is then passed onto the NF-κB-inducing kinase (NIK), which in turn phosphorylates and activates an alpha IKK catalytic dimer. This activated catalytic dimer phosphorylates serine residues in the C-terminal domain of p100<ref>DOI 10.1101/cshperspect.a000034</ref>. This phosphorylation prompts partial proteolysis, creating a p52/RelB complex which will go on to enter the nucleus and bind to DNA.
Alternatively, NF- κB can be activated through the non-canonical pathway, however it affects mainly p100/RelB complexes. The non-canonical pathway is initiated upon binding of very specific ligands (B-cell activating factor, CD40, etc.). This cellular signal is then passed onto the NF-κB-inducing kinase (NIK), which in turn phosphorylates and activates an alpha IKK catalytic dimer. This activated catalytic dimer phosphorylates serine residues in the C-terminal domain of p100<ref>DOI 10.1101/cshperspect.a000034</ref>. This phosphorylation prompts partial proteolysis, creating a p52/RelB complex which will go on to enter the nucleus and bind to DNA.

Revision as of 13:21, 13 October 2015

NF- κB

Caption for this structure

Drag the structure with the mouse to rotate



References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Muller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC. Structure of the NF-kappa B p50 homodimer bound to DNA. Nature. 1995 Jan 26;373(6512):311-7. PMID:7830764 doi:http://dx.doi.org/10.1038/373311a0
  3. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006 Oct 30;25(51):6680-4. PMID:17072321 doi:http://dx.doi.org/10.1038/sj.onc.1209954
  4. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. doi:, 10.1101/cshperspect.a000034. PMID:20066092 doi:http://dx.doi.org/10.1101/cshperspect.a000034

Proteopedia Page Contributors and Editors (what is this?)

Korbin H.J. West

Personal tools